AI assistant
Sending…
Wave Life Sciences Ltd. — Director's Dealing 2022
Jan 5, 2022
31900_dirs_2022-01-04_69b815fc-3508-4b1b-b66b-267e324692e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2022-01-01
Reporting Person: BOLNO PAUL (Director, See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-01 | Share Option (right to buy) | $3.14 | A | 600000 | Acquired | 2032-01-01 | Ordinary Shares (600000) | Direct |
Footnotes
F1: The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.
More from Wave Life Sciences Ltd.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 15
Major Shareholding Notification
2026
Mar 31
Director's Dealing
2026
Mar 31
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 28
Annual Report
2026
Feb 26